Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
COR
HoldCencora, Inc. · Healthcare · United States · $61.5B · Avg Vol: $428M/d
COMPANY DESCRIPTION
Cencora (formerly AmerisourceBergen) is a leading global pharmaceutical sourcing and distribution services company, connecting drug manufacturers with healthcare providers worldwide. As one of the "Big Three" U.S. pharmaceutical distributors, it commands significant market share and benefits from immense scale, sophisticated logistics, and critical supply chain integration. Its robust network and high barriers to entry provide a strong competitive moat in the essential healthcare supply chain.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 238.6B | 262.2B | 294.0B | 321.3B | 10.4% | 332.8B | 337.2B | 355.2B | 5.1% |
| EPS | 8.15 | 8.62 | 7.60 | 8.02 | -0.5% | 13.48 | 8.96 | 9.92 | 11.2% |
| Shares | 206.2M | 200.8M | 194.9M | 193.9M | -5.9% | 190.8M | — | — | — |
| Debt | 5.7B | 4.8B | 4.4B | 7.7B | 10.3% | 14.5B | — | — | — |
| Equity | -211.6M | 522.0M | 645.9M | 1.5B | 70.0% | — | — | — | — |
| Op CF | 2.7B | 3.9B | 3.5B | 3.9B | 12.8% | 4.8B | — | — | — |
| Inv CF | -368.4M | -2.6B | -618.1M | -5.0B | — | — | — | — | — |
| Fin CF | -1.8B | -2.2B | -2.3B | 2.2B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of COR are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| COR | Cencora, Inc.(you) | $61.5B | 65 | Hold |
| MCK | McKesson Corporation | $104.2B | 75 | Buy |
| CAH | Cardinal Health, Inc. | $54.6B | 91 | Strong Buy |
| SIG.AX | Sigma Healthcare Limited | $22.1B | 51 | Hold |
| GALE.SW | Galenica AG | $5.2B | 60 | Hold |
| HSIC | Henry Schein, Inc. | $10.0B | 84 | Strong Buy |
| 601607.SS | Shanghai Pharmaceuticals Holding Co., Ltd | $9.0B | 83 | Strong Buy |
| 600332.SS | Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | $4.9B | 57 | Hold |
| 600998.SS | Jointown Pharmaceutical Group Co., Ltd | $3.7B | 70 | Buy |
| ASKER.ST | Asker Healthcare Group AB (publ) | $3.1B | 72 | Buy |
Peer medians: ROE 2.0% · P/E 24.0x · Gross margin 52.2%